Sulfasalazine is a disease-modifying antirheumatic drug (DMARD) used in the treatment and management of autoimmune conditions such as rheumatoid arthritis and inflammatory bowel disease. This activity reviews the indications, contraindications, mode of action, adverse events, and other key elements of sulfasalazine therapy in the clinical setting as relates to the essential points needed by members of an interprofessional team managing the care of patients with inflammatory bowel disease and rheumatoid arthritis and its related conditions and sequelae.

**Objectives:**
- Explain the mechanism of action of sulfasalazine.
- Describe the adverse effects and contraindications of sulfasalazine.
- Identify appropriate monitoring steps and toxicity of sulfasalazine.
- Outline interprofessional team strategies for improving care coordination and communication to advance sulfasalazine and improve outcomes.